A law blog on intellectual property worth noting is the IP Thinktank Blog [1] by Duncan Bucknell, an independent IP consultant. Hailing from Victoria, Australia [2], IP Thinktank provides one of the best round-ups of IP law from across the globe.
This is a very thorough, well-laid out blog that provides good insight into strategic lifecycle management for both innovator (brandname) pharmaceutical companies as well as generic companies.
One recent post lists the Top 5 reasons not to settle IP Litigation from the IP owner’s perspective:
- The other side are not even close to offering a reasonable deal.
- A state sanctioned monopoly is worth a lot more to you, even after the costs of litigation.
- This is one of many similar actions currently ongoing and you need a precedent and to send a signal to (a) the market, and (b) the other infringers.
- Settling this one will create a cascade of difficulties across many jurisdictions.
- Your CEO just doesn’t get along with the person in charge of that other company (NOT).
You can also learn the word Champerty [3] — a doctrine of law which forbids certain situations in which a third party pays litigation expenses in return for a share in any proceeds.
We recommend adding IP Thinktank to your list.